Lipopolysaccharide activates ERK-PARP-1-RelA pathway and promotes nuclear factor-κB transcription in murine macrophages

Human Immunology

Volumn 73, Issue 5, 2012, Pages 439-447

  Liu, Linlin ^a   Ke, Yueshuang ^a   Jiang, Xue ^a   He, Fen ^a   Pan, Lang ^a   Xu, Li ^a   Zeng, Xianlu ^a   Ba, Xueqing ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

ERK; Inflammation; LPS; NF B; PARP 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IMMUNOPRECIPITATION; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SEPSIS; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL LINE; GENE EXPRESSION; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION;

EID: 84862827170     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.02.002     Document Type: Article

References (28)

1. Schreiber V., Dantzer F., Ame J.C., de Murcia G. Poly(ADP-ribose): Novel functions for an old molecule. Nat Rev Mol Cell Biol 2006, 7:517-528.
2. Woodhouse B.C., Dianov G.L. Poly ADP-ribose polymerase-1: An international molecule of mystery. DNA Repair (Amst) 2008, 7:1077-1086.
3. Yamada M., Miwa M., Sugimura T. Studies on poly (adenosine diphosphate-ribose). X. Properties of a partially purified poly (adenosine diphosphate-ribose) polymerase. Arch Biochem Biophys 1971, 146:579-586.
4. D'Amours D., Desnoyers S., D'Silva I., Poirier G.G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999, 342:249-268.
5. Jagtap P., Szabó C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 2005, 4:421-440.
6. Andrabi S.A., Kim N.S., Yu S.W., Wang H., Koh D.W., Sasaki M., et al. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci U S A 2006, 103:18308-18313.
7. Shieh W.M., Amé J.C., Wilson M.V., Wang Z.Q., Koh D.W., Jacobson M.K., et al. Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers. J Biol Chem 1998, 273:30069-30072.
8. Liaudet L., Pacher P., Mabley J.G., Virág L., Soriano F.G., Haskó G., et al. Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002, 165:372-377.
9. Zerfaoui M., Naura A.S., Errami Y., Hans C.P., Rezk B.M., Park J., et al. Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: Differential effects on CXCR2 ligands and Duffy Antigen receptor for chemokines. J Leukoc Biol 2009, 86:1385-1392.
10. Ba X., Gupta S., Davidson M., Garg N.J. Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes. J Biol Chem 2010, 285:11596-11606.
11. García S., Bodaño A., González A., Forteza J., Gómez-Reino J.J., Conde C. Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice. Arthritis Res Ther 2006, 8:R14.
12. Oumouna M., Datta R., Oumouna-Benachour K., Suzuki Y., Hans C., Matthews K., et al. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: A potential specific effect on IL-5. J Immunol 2006, 177:6489-6496.
13. Havranek T., Aujla P.K., Nickola T.J., Rose M.C., Scavo L.M. Increased poly(ADP-ribose) polymerase (PARP)-1 expression and activity are associated with inflammation but not goblet cell metaplasia in murine models of allergen-induced airway inflammation. Exp Lung Res 2010, 36:381-389.
14. von Lukowicz T., Hassa P.O., Lohmann C., Borén J., Braunersreuther V., Mach F., et al. PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc Res 2008, 78:158-166.
15. Oumouna-Benachour K., Hans C.P., Suzuki Y., Naura A., Datta R., Belmadani S., et al. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: Effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation 2007, 115:2442-2450.
16. Szabó C., Zanchi A., Komjáti K., Pacher P., Krolewski A.S., Quist W.C., et al. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002, 106:2680-2686.
17. Garcia Soriano F., Virág L., Jagtap P., Szabó E., Mabley J.G., Liaudet L., et al. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation. Nat Med 2001, 7:108-113.
18. Jog N.R., Dinnall J.A., Gallucci S., Madaio M.P., Caricchio R. Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation. J Immunol 2009, 182:7297-7306.
19. Genovese T., Cuzzocrea S. Role of free radicals and poly(ADP-ribose) polymerase-1 in the development of spinal cord injury: New potential therapeutic targets. Curr Med Chem 2008, 15:477-487.
20. Goldberg M.S., Xing D., Ren Y., Orsulic S., Bhatia S.N., Sharp P.A. Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells. Proc Natl Acad Sci U S A 2011, 108:745-750.
21. Kauppinen T.M., Chan W.Y., Suh S.W., Wiggins A.K., Huang E.J., Swanson R.A. Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2. Proc Natl Acad Sci U S A 2006, 103:7136-7141.
22. Boulares A.H., Zoltoski A.J., Sherif Z.A., Jolly P., Massaro D., Smulson M.E. Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Respir Cell Mol Biol 2003, 28:322-329.
23. Zerfaoui M., Suzuki Y., Naura A.S., Hans C.P., Nichols C., Boulares A.H. Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction. Cell Signal 2008, 20:186-194.
24. Amiri K.I., Ha H.C., Smulson M.E., Richmond A. Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1. Oncogene 2006, 25:7714-7722.
25. Zerfaoui M., Errami Y., Naura A.S., Suzuki Y., Kim H., Ju J., et al. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J Immunol 2010, 185:1894-1902.
26. Hassa P.O., Covic M., Hasan S., Imhof R., Hottiger M.O. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem 2001, 276:45588-45597.
27. Ba X., Garg N.J. Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases. Am J Pathol 2011, 178:946.
28. Torres M. Mitogen-activated protein kinases pathways in redox signaling. Front Biosci 2003, 8:d369-d391.